Back to Report Store Home

Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose

  • Published: Oct-2012
  • Report Code: GBIHC265MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Seasonal Influenza Vaccine Market, Top Seven Countries, Revenue Forecasts ($m), 2011–2018

Figure 2: Seasonal Influenza Vaccine Market, Top Seven Countries, Vaccination Coverage (%), 2011–2018

Figure 3: Seasonal Influenza Vaccine Market, Top Seven Countries, Population (‘000), 2011–2018

Figure 4: Seasonal Influenza Vaccine Market, Top Seven Countries, Vaccination Coverage by Age Group (%), 2011–2018

Figure 5: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Doses by Age Group (‘000), 2011–2018

Figure 6: Seasonal Influenza Vaccine Market, Top Seven Countries, Revenue Forecasts ($m), 2011–2018

Figure 7: Seasonal Influenza Vaccine Market, Top Seven Countries, Drivers and Restraints

Figure 8: Seasonal Influenza Vaccine Market, The US, Population (‘000), 2011–2018

Figure 9: Seasonal Influenza Vaccine Market, The US, Vaccination Coverage by Age Group (%), 2011–2018

Figure 10: Seasonal Influenza Vaccine Market, The US, Number of Doses by Age Group (‘000), 2011–2018

Figure 11: Seasonal Influenza Vaccine Market, The US, Revenue Forecasts ($m), 2011–2018

Figure 12: Seasonal Influenza Vaccine Market, The US, Drivers and Restraints

Figure 13: Seasonal Influenza Vaccine Market, The UK, Population (‘000), 2011–2018

Figure 14: Seasonal Influenza Vaccine Market, The UK, Vaccinated Coverage by Age Group (%), 2011–2018

Figure 15: Seasonal Influenza Vaccine Market, The UK, Number of Doses by Age Group (‘000), 2011–2018

Figure 16: Seasonal Influenza Vaccine Market, The UK, Revenue Forecasts ($m), 2011–2018

Figure 17: Seasonal Influenza Vaccine Market, The UK, Drivers and Restraints

Figure 18: Seasonal Influenza Vaccine Market, France, Population (‘000), 2011–2018

Figure 19: Seasonal Influenza Vaccine Market, France, Vaccination Coverage by Age Group (%), 2011–2018

Figure 20: Seasonal Influenza Vaccine Market, France, Number of Doses by Age Group (‘000), 2011–2018

Figure 21: Seasonal Influenza Vaccine Market, France, Revenue Forecasts ($m), 2011–2018

Figure 22: Seasonal Influenza Vaccine Market, France, Drivers and Restraints

Figure 23: Seasonal Influenza Vaccine Market, Italy, Population (‘000), 2011–2018

Figure 24: Seasonal Influenza Vaccine Market, Italy, Vaccination Coverage by Age Group (%), 2011–2018

Figure 25: Seasonal Influenza Vaccine Market, Italy, Number of Doses by Age Group (‘000), 2011–2018

Figure 26: Seasonal Influenza Vaccine Market, Italy, Revenue Forecasts ($m), 2011–2018

Figure 27: Seasonal Influenza Vaccine Market, Italy, Drivers and Restraints

Figure 28: Seasonal Influenza Vaccine Market, Spain, Population (‘000), 2011–2018

Figure 29: Seasonal Influenza Vaccine Market, Spain, Vaccination Coverage by Age Group (%), 2011–2018

Figure 30: Seasonal Influenza Vaccine Market, Spain, Number of Doses by Age Group (‘000), 2011–2018

Figure 31: Seasonal Influenza Vaccine Market, Spain, Revenue Forecasts ($m), 2011–2018

Figure 32: Seasonal Influenza Vaccine Market, Spain, Drivers and Restraints

Figure 33: Seasonal Influenza Vaccine Market, Germany, Population (‘000), 2011–2018

Figure 34: Seasonal Influenza Vaccine Market, Germany, Vaccination Coverage by Age Group (%), 2011–2018

Figure 35: Seasonal Influenza Vaccine Market, Germany, Number of Doses by Age Group (‘000), 2011–2018

Figure 36: Seasonal Influenza Vaccine Market, Germany, Revenue Forecasts ($m), 2011–2018

Figure 37: Seasonal Influenza Vaccine Market, Germany, Drivers and Restraints

Figure 38: Seasonal Influenza Vaccine Market, Japan, Population (‘000), 2011–2018

Figure 39: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage by Age Group (%), 2011–2018

Figure 40: Seasonal Influenza Vaccine Market, Japan, Number of Doses by Age Group (‘000), 2011–2018

Figure 41: Seasonal Influenza Vaccine Market, Japan, Revenue Forecasts ($m), 2011–2018

Figure 42: Seasonal Influenza Vaccine Market, Japan, Drivers and Restraints

Figure 43: Seasonal Influenza Vaccine Market, Regulatory Authorities, The US, 2012

Figure 44: Seasonal Influenza Vaccine Market, Drug Approval Process, The US, 2012

Figure 45: Seasonal Influenza Vaccine Market, Regulatory Authorities, EU, 2012

Figure 46: Seasonal Influenza Vaccine Market, Approval Process, EU, 2012

Figure 47: Seasonal Influenza Vaccine Market, Regulatory Authorities, Japan, 2012

Figure 48: Seasonal Influenza Vaccine Market, Drug Approval Process, Japan, 2012

Figure 49: Seasonal Influenza Vaccine Market, Top Seven Countries, R&D Pipeline by Phase (%), 2012

Figure 50: Seasonal Influenza Vaccine Market, Top Seven Countries, Market Share (%), 2011

Figure 51: Seasonal Influenza Vaccine Market, Top Seven Countries, Sanofi, SWOT Analysis

Figure 52: Seasonal Influenza Vaccine Market, Top Seven Countries, GSK, SWOT Analysis

Figure 53: Seasonal Influenza Vaccine Market, Top Seven Countries, Novartis, SWOT Analysis

Figure 54: Seasonal Influenza Vaccine Market, Top Seven Countries, AstraZeneca, SWOT Analysis

Figure 55: Seasonal Influenza Vaccine Market, Top Seven Countries, Deals by Type, 2009–2012

Figure 56: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Deals by Year, 2009–2012

Figure 57: Seasonal Influenza Vaccine Market, Top Seven Countries, M&A Deals by Geography, 2009–2012

Figure 58: Seasonal Influenza Vaccine Market, Top Seven Countries, M&A Deals by Year, 2009–2012

Figure 59: Seasonal Influenza Vaccine Market, Top Seven Countries, Licensing Agreements by Geography, 2009–2012

Figure 60: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Licensing Agreements by Year, 2009–2012

Figure 61: Seasonal Influenza Vaccine Market, Top Seven Countries, Partnership Deals by Geography, 2009–2012

Figure 62: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Partnership Deals by Year, 2009–2012

Figure 63: GBI Research Market Forecasting Model, Estimation of Market for a Country, 2010

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards